Jan 8, 2019 | Health and Wellness
Dr. Beurkens specializes in resolving problems that many families and professionals deem unsolvable.
She recognizes that beneath the many challenging symptoms children and young adults exhibit are people capable of more.
Her patients and their families affectionately refer to her as the learning and behavior “detective.” Many people believe that the symptoms they experience are the problem, but the symptoms are actually clues to the real problems
Contact:-
Dr. Nicole Beurkens
3120 68th St SE,
Caledonia, MI 49316, USA
616-698-0306
https://www.drbeurkens.com
Social NetWork:-
https://www.facebook.com/drnicolebeurkens
https://twitter.com/drbeurkens
https://www.youtube.com/channel/UCOfWp-qkLCcrsMmGY8xZmoQ
https://vimeo.com/user56837158
https://www.drbeurkens.com/blog/
Jan 8, 2019 | Health and Wellness
The market for platelet rich plasma (PRP) Europe is expected to reach US$ 37.5 Mn in 2016, up from US$ 35.3 Mn in 2015. Adoption of platelet rich plasma in treating musculoskeletal injuries, including tennis elbow, Achilles tendinopathy, and plantar fasciitis, will continue to drive revenues. PRP therapy is also gaining traction in treating sports-related and geriatric injuries, owing to its minimally invasive procedure and quicker recovery time.
By product type, PRP kits will continue to outsell instruments, accounting for over 75% revenue share of the market in 2016. Among the various platelet rich plasma kits, autologous kits will account for the highest demand on the basis of blood type, representing a market value worth US$ 24.2 Mn. P-PRF kits—valued at US$ 10 Mn in 2015—will witness the highest growth by end-product type, increasing at 8.6% in 2016.
By application, adoption of PRP therapy will continue to remain highest in the treatment of knee and elbow injuries. While knee application segment revenues will grow by 7.2%, elbow application segment revenues are projected to grow by 6.3%. Use of PRP therapy in the treatment of ever-increasing incidences of osteoarthritis and tennis elbow will gain further traction in 2016 and beyond.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-eu-1599
PRP revenues in the UK—the largest market in Europe—will grow by 7.3% in 2016, an increase of 0.20% from the 7.1% growth in 2015. High prevalence of sports-related incidents in the U.K., combined with high awareness about the benefits of PRP therapy among healthcare community and patients, will continue to fuel the growth of the market in the country.
France will maintain its position as the second largest market for PRP in Europe, growing by 6.5% in terms of revenues in 2016. France is home to subsidiaries and distributors of several PRP players, such as Biomet, Inc., DePuy Synthes, Inc., and Stryker Corporation and a range of highly innovative products are available in the market.
Johnson & Johnson Inc. and Stryker Corporation are the established players in the Europe PRP market. Johnson & Johnson’s PEAK™ Platelet Rich Plasma System and Stryker Corporation’s RegenKit THT Autologous Platelet-rich Plasma (A-PRP) will continue to witness sizeable sales in 2016. Arthrex – Arthrex Angel System™ from Arthrex Inc. and GPS® III Platelet Separation System by Zimmer Biomet Holdings Inc. will also account for substantial revenue share of the Europe PRP market.
Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-eu-1599
Competitive Landscape
Some of the key players identified in the European PRP market report include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd, Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., and Regen Lab S.A. The report offers invaluable insights into company-specific strategies related to PRP market, market consolidation initiatives and analyses of the various market players’ specific strengths, weaknesses, opportunities and threats. Companies are focusing on developing innovative products in order to remain competitive in the Europe PRP market.
Long-term Outlook: The PRP market in Europe is expected to increase at a CAGR of 6.6% during the forecast period 2016-2024. The UK will continue to be at the forefront of overall demand, with France and Germany accounting for sizeable market share. While FMI maintains a positive outlook on the Europe PRP market, challenges, including lack of standardisation in preparation and dosage of autologous blood concentrate, and uncertainty about therapy efficacy can impede growth during the forecast period.
Jan 8, 2019 | Health and Wellness
Tip location devices are being increasingly used for confirmation of PICC tip location during PICC insertion, owing to their advantages, such as meticulous precision and low-price. Tip location devices are emerging as a credible alternative to the more expensive methods used for PICC tip confirmation, such as X-ray and fluoroscopy. These factors are expected to fuel the growth of the US$ 27 Mn global tip location devices market, according to a new report by Future Market Insights (FMI). The report, titled, “Tip Location Devices Market: Global Industry Analysis and Opportunity Assessment, 2016-2026”, projects 6.4% CAGR for the global tip location devices market during the forecast period 2016-2026.
FMI’s report offers market forecast and analysis on the global tip location devices market, segmenting the market on the basis of product, technology, end-user, and region.
North America Largest Market Globally
According to FMI’s region-wise analysis, North America (U.S. and Canada) is the most lucrative market for tip location devices globally. The region accounted for 42.2% revenue share of the global tip location devices market in 2015, and is expected to increase at 7.1% CAGR during the forecast period, 2016-2026. Asia Pacific excluding Japan (APEJ), an emerging market for tip location devices, accounted for 8.0% revenue share of the market in 2015.
On the basis of product, FMI’s report has segmented the market into tip location devices and accessories. The former dominates global revenues in terms of value, whereas the latter has higher market share in terms of volume.
On the basis of technology, the tip location devices market has been segmented into ECG tip confirmation, ECG with magnetic tracking and ECG & intravascular Doppler. Tip location devices that use ECG & intravascular Doppler technology are expected to witness higher demand than devices that use only ECG technology and devices that use ECG with magnetic tracking.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-880
Key end-use sectors that generate the bulk of demand for tip location devices can be broadly categorised into hospitals, ambulatory surgical centres, and catheterization labs. Among these, hospitals account for the largest revenue share of the market, owing to increasing number of PICC insertion procedures carried out in hospitals.
Drivers and Trends
Increasing prevalence of chronic diseases, such as cancer, is leading to the rise in adoption of PICC procedures as PICC are used for administration of antibiotics, parenteral nutrition and for chemotherapy across the globe, which in turn is expected to fuel revenue growth of the tip location devices market globally over the forecast period. Cost-effectiveness offered by tip location devices in case of PICC tip confirmation as compared to X-ray and fluoroscopy and increased precision of PICC placement is further fueling revenue growth of the tip location devices market currently. Lack of clinical data regarding tip location devices and dearth of skilled professionals to operate the device are few factors expected to hamper growth of the global tip location devices market to a certain extent. Major trends in the tip location devices market include product modifications and innovations, strategic marketing campaigns and partnerships and acquisitions to increase consumer base.
Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-880
Analysis, by Region
North America is expected to dominate the global tip location devices market and is projected to register a CAGR of 7.1% in terms of value over the forecast period. The tip location devices market in the U.S is expected to dominate the North America tip location devices market throughout the forecast period. The North America tip location devices market accounted for 42.2% revenue share of the overall market in 2015. The Japan market is projected to expand at a healthy CAGR of 6.1% during the forecast period. The APEJ market is estimated to account for 8.1% revenue share of the global tip location devices market by the end of 2016.
Key companies profiled in FMI’s report include C.R. Bard, Inc., Teleflex Incorporated, AngioDynamics Inc., Vygon S.A. and CORPAK MedSystems
Jan 8, 2019 | Health and Wellness
Premium Billing works on a belief that every doctor in the country has right towards his/her full payment for providing their services to their patients. Insurance companies are not fully helpful for the doctors to get their unaccountable dollar. They use to make complex procedures which make it extremely difficult for the doctors to process their payments through this and also consume a lot of their valuable time. We have years of experience in dealing with insurance companies, thus making sure that practitioners get full payment for their claim.
Premium Billing is an expert in providing medical billing outsourcing services to health care providers. Medical or healthcare organizations likely to suffer huge losses due to coding errors, under-pricing, missed charges and non-reimbursed claims. We work as a mediator between insurance companies and health care organizations or hospitals and give our best to reduce the occurrence of such losses. Outsourcing your medical billing services allows your organization to reduce operational expenses and also helps you to run generate more revenue by eliminating above mentioned losses.
All healthcare practitioners believe in delivering their best services to their patients simultaneously wants to ensure to generate more revenue and want their healthcare organization or hospital to grow its roots. But it cannot be attained if your revenue cycle management is poor. Premium billing also works as a medical billing collection agency to help you in enhancing your revenue cycle management efficiency by effective and efficient management of your billing and collection functions.
Our company is a team of expert and experienced people who have in-depth knowledge of the variety of billing process, healthcare plans and methods. We use extensive accounting procedures to calculate revenue and to ensure that all your payments are made on time. Our company also provides medical billing and coding services thus helping you to eliminate your operational expenses and hence generating more revenue.
Contact Us:-
Business Name: Premium Billing
Address: 544 Park Ave #633
City: Brooklyn, NY
Zip Code: 11205
Phone: 718-384-6500
Email: info@PremiumBilling.info
Web: http://premiumbillingonline.com/
Jan 8, 2019 | Health and Wellness
Global shipments of wearable medical devices will surpass 106 million in 2016, as rising awareness and disposable income continue to influence healthcare decisions. Global wearable medical device revenues are set to touch US$ 23,980.5 million, witnessing a y-o-y growth of 4.8% in 2016 over 2015.
Increasing prevalence of diseases that require round-the-clock monitoring will continue to ramp up demand for wearable medical devices in 2016. Availability of compact, smartphone-compatible devices is also expected to boost adoption. Although average selling price of these devices is expected to witness a decline in 2016, high price still remains a key constraint for many patients. As technology makes further headway and competition become more intense, wearable medical devices are anticipated to become more affordable in the future.
Wearable monitoring and diagnostic devices will continue to witness the highest demand in 2016, followed by wearable therapeutic medical devices. However, the latter will continue to account for higher revenues, owing to higher average selling price of these devices. Total shipments of wearable therapeutic medical devices are anticipated to reach 38,637,108 in 2016, representing market value worth US$ 14,543.6 Mn. Sleep apnea devices will continue to be the highest-selling wearable therapeutic medical device, with total shipments expected to reach 34,008,685 in 2016.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-826
Patient monitoring, home healthcare, and health & fitness will continue to remain the key end use application segments of wearable medical devices in 2016. Demand for wearable medical devices will be strongest in home healthcare segment, with total revenues expected to reach US$ 15,281.5 Mn in 2016. Wearable medical devices are gaining traction in the rapidly growing home healthcare sector, giving care providers and patients access to crucial physiological information.
Clinics will continue to be the leading distribution channel for wearable medical devices in 2016. Clinics will sell US$ 7,717.0 Mn worth of wearable medical devices in 2016, up from US$ 7,348.4 Mn in 2015. Sales will continue to gain traction through online channels, with total revenues expected to reach US$ 4,669.0 Mn, a y-o-y increase of 4.6% in 2016 over 2015.
North America will continue to be the largest market, followed by Western Europe and Asia Pacific excluding Japan (APEJ). The North America wearable medical devices market will reach US$ 9,608.7 Mn in 2016, up from US$ 9,143.2 Mn in 2015.
Medtronic plc, Koninklijke Philips N.V., Sonova, and Fitbit Inc. are the leading players in wearable medical device market. Geographical expansion, investment in start-ups and SMEs remains the key business strategy of these players.
Key Regions
The global wearable medical devices market has been segmented into seven major regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). In terms of value, the North America market has been estimated to dominate the global wearable medical devices market in 2016, and is expected to witness highest CAGR of 7.4% over the forecast period. APEJ, Western Europe and Japan are estimated to be the fastest growing markets among regional markets. APEJ market is expected to expand at a CAGR of 7.0% over the forecast period. In North America, wearable monitoring and diagnostic device segment is expected to grow at faster rate to reach the value US$ 6,920.2 Mn by 2026 end. Market in MEA is expected to exhibit subdued market growth owing to lower adoption of wearable devices in the region.
Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-826
Key Players
Some of the key players in the global wearable medical devices market include Medtronic plc, Siemens AG, Fitbit Inc., Bayer AG, Panasonic Corporation, Animas Corporation- Johnson and Johnson, Smiths Medical – A Smiths Group Company, Koninklijke Philips N.V., Owlet Baby Care, OMRON Corporation, Hoffmann-La Roche Ltd and Rest Devices Inc.
Long-term Strategy: FMI projects the global wearable medical devices market to expand at 6.9% CAGR during the forecast period 2016-2026.
Jan 8, 2019 | Health and Wellness
For professional & personal use: The new and attractive range of both Aneroid and Digital blood pressure monitors have been introduced. Coming in 2 types as Upper arm and Wrist blood pressure monitors. With 50% of America suffering from high Blood pressure problems a personal device is very much necessary.
An early detection of high and low blood pressure can result in avoidance of many life threatening situations like Heart attack or a stroke and can also damage your Brain, Eyes and Kidney. But once a while measurement of your BP won’t do, it needs to be measured several times a day continuously for few days. For this a personal blood pressure monitor with good quality and features is required, especially for the elderly.
SantaMedical is an established name in the Healthcare industry with its range of tested and widely used digital products. The quality and accuracy of its products have earned it a distinction in the market today. Their products include Digital upper arm, Digital Wrist, and Aneroid upper arm Blood pressure monitors.
According to a survey 50% of Americans suffer from high blood pressure and hence regularly need to keep checking their BP. SantaMedical blood pressure monitors are a perfect fit for them. Combining latest technology of microcontrollers and advanced display, they have crafted products that are used by medical professionals all over the US.
“The readings are accurate and we have been using the same set for the last 3 years” say Doctors. The extra large display helps the elderly to easily monitor their BP without any help.
About Us
Gurin products, LLC is a company based in California, USA. Gurin products are devoted to designing, developing and manufacturing innovative Healthcare products that meet the needs of our customers through our GURIN and SANTAMEDICAL brands. For more info or to contact us log in to our website:- Santamedical.com
